Header Logo

Connection

GIULIO DRAETTA to Glutaminase

Back to Details
This is a "connection" page, showing publications GIULIO DRAETTA has written about Glutaminase.
GIULIO DRAETTA
Connection Strength
0.174
Glutaminase
  1. Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties. J Med Chem. 2020 11 12; 63(21):12957-12977.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.